Skip to main content
. 2016 Jan 21;23(3):272–282. doi: 10.1038/gt.2015.112

Figure 2.

Figure 2

AAV2-2 transduces large projection neurons, mainly CSMN in the motor cortex. Co-immunolabeling with eGFP and cell-type-specific markers reveals transduction efficiencies of neurons (a) and CSMN (b) in the motor cortex. (a) A representative image of AAV2-2 eGFP+-transduced cells expressing NeuN. Boxed areas in representative images are enlarged to the right. (b) A representative image of AAV2-2 eGFP+-transduced cells expressing Ctip2. (cf) Bar graphs represent mean percentage ±s.e.m. of neurons (eGFP+ cells, expressing neuronal marker NeuN) (c), CSMN (eGFP+ cells, expressing Ctip2) (d), astrocytes (eGFP+ cells, expressing GFAP) (e) and microglia (eGFP+ cells, expressing Iba1) (f). One-way ANOVA and Tukey's multiple comparison test, AAV2-2 versus all other serotypes. *P<0.05, **P<0.01, ***P<0.001. Scale bars 10 μm (b), 50 μm (d, e).